ClinicalTrials.Veeva

Menu

Vascular Responses to Sympathetic Activation and Altered Shear Rate: The Impact of Hypertension and Sodium Intake

Virginia Commonwealth University (VCU) logo

Virginia Commonwealth University (VCU)

Status

Completed

Conditions

Hypertension

Treatments

Dietary Supplement: Salt Pills
Dietary Supplement: Placebo Pills

Study type

Interventional

Funder types

Other

Identifiers

NCT03558022
HM20013060

Details and patient eligibility

About

The aim of this study is to determine if alterations in sodium intake alter peripheral vascular function and exercise tolerance in young individuals.

Full description

Sodium intake is a major contributor to the development of hypertension in the developed world. Interestingly, it has been recently revealed that, in addition to the cardiovascular dysfunction associated with high sodium intake-induced hypertension, individuals who have unaltered blood pressure after chronic high sodium intake, termed salt resistant, report similar reductions in cardiovascular function when compared to salt sensitive individuals. While the extent to which this high sodium intake negatively alters cardiovascular structure as well as function is currently being explored, little is known about how high sodium intake impacts vascular function and blood flow regulation during exercise. Therefore, this study will determine if alterations in sodium intake alter peripheral vascular function and exercise tolerance in young individuals. The investigators hypothesize that increases in sodium intake will reduce exercise-induced arterial dilation in response to shear and result in exercise intolerance, via impaired functional sympatholysis, at moderate-to-high exercise workloads. Furthermore, the investigators hypothesize that these changes in blood flow regulation and exercise tolerance in young individuals will be reversed following antioxidant supplementation, implicating the role of oxidative stress in this dysfunction.

Enrollment

34 patients

Sex

All

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • normotensive blood pressure (Systolic <120 AND Diastolic <80
  • free of cardiovascular disease and any evidence of thyroid, renal, metabolic, pulmonary or neurological disease
  • non-obese (BMI <30 and/or Body fat < 25% for men, and < 30% for women)
  • no tobacco use
  • no medications that could affect vascular function or oxidative stress
  • not sedentary

Exclusion criteria

  • individual with cardiovascular, pulmonary, or metabolic disease or taking medications that may alter cardiovascular, pulmonary, or metabolic function
  • subjects will be asked to maintain a dietary record for one week subsequent to the pre-screening and if this reveals a diet that differs substantially from the "typical" average diet, the subject will not be eligible
  • subjects will be excluded from the study if dietary records reveal significant caloric restriction and/or vitamin/mineral deficiencies
  • pregnant women, prisoners, and children will not be eligible for this study

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

34 participants in 2 patient groups, including a placebo group

Salt Pills
Experimental group
Description:
One week on low salt diet plus salt pills
Treatment:
Dietary Supplement: Salt Pills
Placebo Pills
Placebo Comparator group
Description:
One week on low salt diet plus placebo pills
Treatment:
Dietary Supplement: Placebo Pills

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems